Age as anan independent factor for the development of neuropathy in diabetic patients.
Popescu Simona, Timar Bogdan, Baderca Flavia et al. Egyptian Journal of Medical Research (EJMR) vol 1, issue 1. Gender differences in diabetic peripheral neuropathy. 2015Ībuse Mona Ali, Elmasry Hatem Anwar, Oraby Mohammed Ibrahim et al. Microvascular complications and foot care: standards of medical care in diabetes 41(Suppl. Available from : Īmerican Diabetes Association, 2018. Updates in diabetic peripheral neuropathy. Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 di Indonesia. Pusat data dan informasi kementrian kesehatan RI 2018. The evaluation and treatment of diabetic foot ulcers and diabetic foot infections. From the analysis with Chi-Square, we did not find a significant association between the duration of type 2 diabetes mellitus and peripheral diabetic neuropathy (p = 0.004).Ĭonclusion: There was no statistically significant association between the duration of type 2 diabetes mellitus and the prevalence of peripheral diabetic neuropathy.ĭel Michael A. This chronic complication is divided into two groups based on the duration of diabetes mellitus type 2 with the prevalence of peripheral diabetic neuropathy with a duration of diabetes <5 years (18,2%) and peripheral diabetic neuropathy with the duration of diabetes more than equal to five years old (35,7%). The prevalence of patients with peripheral diabetic neuropathy was 28% from all subjects. Result: Among 50 subjects who participated in the study, most were women (78%). The score of the MNSI questionnaire is analyzed using Chi-Square Test. The sampling technique used consecutive sampling with filling out the Michigan Neuropathy Screening Instrument (MNSI) questionnaire. Method: A cross-sectional study was done using 50 patients in the Outpatient Unit of Gotong Royong Hospital Surabaya. Objective: The purpose of this study was to understand the association of the duration of type 2 diabetes mellitus with the prevalence of peripheral diabetic neuropathy in the Outpatient Unit of Gotong Royong Hospital Surabaya. The screening tool for peripheral diabetic neuropathy is Michigan Neuropathy Screening Instrument (MNSI), which consists questionnaire and physical examination. Promotive and preventive actions are needed to decrease the prevalence of peripheral diabetic neuropathy. Background: Chronic complications of diabetes mellitus have a significant role in increased morbidity, mortality, disability, and health cost as the population increases every year.
0 kommentar(er)
